MEDICOX Co., Ltd. Logo

MEDICOX Co., Ltd.

Manufactures shipbuilding materials and equipment, and develops biopharmaceuticals.

054180 | KO

Overview

Corporate Details

ISIN(s):
KR7054180005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 549 2~3층 (청담동, 블루펄빌딩), 강남구

Description

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-18 00:00
전환청구권행사(제18회차)
Korean 10.2 KB
2023-05-17 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제18회 전환사채 재매각)
Korean 15.8 KB
2023-05-17 00:00
주식등의대량보유상황보고서(일반)
Korean 80.4 KB
2023-05-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2023-05-15 00:00
소송등의판결ㆍ결정(신주발행금지가처분)
Korean 5.6 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean 1.8 MB
2023-05-12 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제18회 전환사채 재매각)
Korean 15.2 KB
2023-05-10 00:00
증권발행결과(자율공시)(제3자배정 유상증자)
Korean 9.0 KB
2023-05-10 00:00
최대주주변경
Korean 28.2 KB
2023-05-03 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 33.8 KB
2023-05-03 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 43.3 KB
2023-05-03 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 80.5 KB
2023-05-03 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 81.5 KB
2023-05-03 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제18회 전환사채 재매각)
Korean 14.4 KB
2023-05-03 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 34.8 KB

Automate Your Workflow. Get a real-time feed of all MEDICOX Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MEDICOX Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MEDICOX Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.